Leading Companies Fueling Growth and Innovation in the Neonatal Point of Care Testing Market

The neonatal point of care testing market is set to experience significant expansion in the coming years, driven by technological advancements and increasing healthcare demands. As innovations continue to shape neonatal diagnostics, this sector is becoming crucial in ensuring timely and accurate care for newborns worldwide. Let's explore the market's projected size, key players, emerging trends, and segmentation in more detail.

Forecasted Growth and Market Size of the Neonatal Point Of Care Testing Industry
The neonatal point of care testing market is projected to grow swiftly, reaching a value of $2.59 billion by 2030. This corresponds to a robust compound annual growth rate of 14.3%. The market's upward trajectory is largely fueled by the integration of AI-based diagnostic tools, advancements in cloud technology for managing neonatal data, and the rise of portable, compact testing devices. Additionally, increased collaboration between public and private sectors to improve newborn health and the development of healthcare infrastructure in emerging economies contribute significantly to this growth. Key trends expected to dominate include AI-powered neonatal diagnostics, cloud-enabled point-of-care platforms, portable testing instruments, real-time data analysis capabilities, and IoT integration for continuous newborn monitoring.

Download a free sample of the neonatal point of care testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28277&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Primary Companies Leading the Neonatal Point Of Care Testing Sector
Several prominent organizations are shaping the neonatal point of care testing market landscape. These include Abbott Laboratories, Siemens Healthineers AG, GE Healthcare Technologies Inc., Koninklijke Philips N.V., Roche Diagnostics International AG, Danaher Corporation, Dräger AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMérieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.l., and GINEVRI Srl.
In a notable development, Belgium-based biotechnology firm LaCAR MDx Technologies acquired the newborn screening division of US-based Baebies Inc. in March 2025. This acquisition strengthens LaCAR's product portfolio and accelerates its expansion into the US market, enhancing its competitive position and growth prospects within neonatal point of care testing.

Emerging Collaboration Trends in the Neonatal Point Of Care Testing Market
Strategic partnerships are becoming a central approach for companies aiming to broaden their market reach and enhance product offerings. These collaborations bring together resources and expertise to achieve mutual growth objectives.
For example, in January 2025, QIAGEN, a Netherlands-based provider of sample and assay technologies, formed a partnership with Genomics England, a UK genomic medicine organization. This alliance launched the Generation Study, which plans to sequence the genomes of 100,000 newborns across England to screen for over 200 actionable genetic disorders. QIAGEN will provide critical clinically relevant variant information for genes included in the point-of-care sequencing test, enabling faster interpretation and reporting of results. The study, officially beginning in October 2024, targets conditions that may affect around 3,000 newborns annually in the UK, supporting timely diagnosis and treatment.

View the full neonatal point of care testing market report:
https://www.thebusinessresearchcompany.com/report/neonatal-point-of-care-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Detailed Segmentation of the Neonatal Point Of Care Testing Market
This report breaks down the neonatal point of care testing market by several key categories:
1) Product Type: Instruments and Assays
2) Test Type: Neonatal Bilirubin Testing, Blood Glucose Testing, Infectious Disease Screening, Electrolyte Testing, and Other Test Types
3) End-Users: Hospitals, Maternity and Specialty Clinics, and Other End-Users

Further subcategories include:
- Instruments such as Blood Gas Analyzers, Bilirubinometers, and Glucose Meters
- Assays including Bilirubin Assays, Glucose Assays, Infectious Disease Assays, Electrolyte Assays, and Blood Gas Assays

This segmentation provides a comprehensive framework for understanding the diverse components and applications within the neonatal point of care testing market.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.